New MD for Takeda Global Research & Development Centre Europe
This article was originally published in Scrip
Dr Stuart Dollow has been named managing director for Takeda Global Research & Development Centre Europe, Takeda's wholly owned subsidiary for pharmaceutical development, which is headquartered in London. He succeeds Dr Steve Coles, who retired on 31 March. Dr Dollow joins from Norgine, where he served as chief development officer. He has also previously worked at Roche in the UK, and Glaxo Wellcome and GlaxoSmithKline in the UK and the US.